
Sovaldi “Biggest Selling Drug” by 2020
Gilead’s hepatitis C treatment Sovaldi will top the list of biggest selling drugs in 2020, according to UK market intelligence company, Evaluate.
Gilead’s hepatitis C treatment Sovaldi will top the list of biggest selling drugs in 2020, according to UK market intelligence company, Evaluate.
“Given its history-making launch, it is no surprise that [Sovaldi] is forecast to become the biggest drug in 2020; the big question will be how long this drug can hang onto the top spot,” said Lisa Urquhart, leader of Evaluate’s EP Vantage editorial team.
For
EP Vantage’s “
Evaluate’s annual report, “World Preview 2014: Outlook to 2020”, examining the impact of patent expirations and analysing R&D spend as well as the leading products and companies, will be launched at next month’s 2014 BIO Convention in San Diego, CA (June 23–26).
For more information on the “Biggest Drugs of 2020″,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.